Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Wnt signaling is crucial for skin development and health, and its disruption can cause skin diseases.

Skin stem cells help repair damage and maintain healthy skin.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Hedgehog signaling can create new hair follicles in adult skin but may increase cancer risk.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Tripeptides help heal wounds and regenerate skin by speeding up tissue repair and reducing inflammation.

miRNAs are crucial for hair growth and skin health.

Snail2 is crucial for hair growth and affects skin cancer development.

Dermoscopy has improved skin cancer diagnosis and has expanding applications in dermatology, but requires staying updated with new research and techniques.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Targeted cancer therapies often cause serious skin problems that need careful management.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Loss of TET2 increases the risk of skin and oral cancer.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

A man developed skin cancer on his scalp after multiple artificial hair grafts.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Aging dermal papilla cells can be reprogrammed for potential hair growth and skin repair.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

Ongoing research and innovation are crucial for improving skin care and treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.